Loading asset research
Eupraxia Pharmaceuticals Inc. Common Stock
EPRXNasdaq · USD · StocksQuote as of · Exchange session not verified$8.42
+4.99%
Today
EPRX
Loading 1D prices…
Market cap
$556.3M
Volume
492.9K
52w high
$9.3252w low
$5.16Company profile
Eupraxia Pharmaceuticals Inc. Common Stock
Eupraxia Pharmaceuticals Inc., a clinical-stage biotechnology company, focuses on the development of products to address therapeutic areas with unmet medical need. Its proprietary Diffusphere technology optimizes drug delivery for applications with significant unmet medical need. The company's product portfolio includes EP-104IAR, which is in Phase III clinical trial for the treatment of knee osteoarthritis; EP-104GI that is in Phase II clinical trial for treating eosinophilic esophagitis; and EP-104, which is under preclinical studies for the treatment of gastrointestinal tract, such as eosinophilic esophagitis. The company was formerly known as Plaza Capital Partners Inc. and changed its name to Eupraxia Pharmaceuticals Inc. in May 2012. Eupraxia Pharmaceuticals Inc. was incorporated in 2011 and is headquartered in Victoria, Canada.
Sector
Health Care
Industry
Pharmaceutical Preparations
Exchange
Nasdaq
Display currency
USD
Location
Victoria, BC, United States
Employees
49
Fiscal year end
1231
CIK
1581178
Session & valuation
Open$8.14
Previous close$8.02
Day high$8.49
Day low$8.11
30-day avg. volume436.8K
Outstanding shares35.6M
Diluted EPS-$1.03
Latest annual period
P/E (trailing)-8.17
P/E (forward)-8.09
Price / book5.42
Beta1.49
Dividend yield—
Deterministic peer set
Companies with SEC SIC 2834
Exact regulatory industry matches, ranked by nearest market capitalization.
| Company | Market cap | Revenue | Net margin | Diluted EPS | Today | Consensus |
|---|---|---|---|---|---|---|
| CTNMContineum Therapeutics Inc. Class A Common Stock | $557.5M | $0.00 | — | -$2.17 | +1.09% | Buy |
| ARVNArvinas Inc. Common Stock | $545.2M | $262.6M | -30.85% | -$1.14 | -2.99% | Hold |
| OCSOculis Holding AG Ordinary shares | $586.4M | — | — | -$1.89 | -6.63% | Buy |
| OVIDOvid Therapeutics Inc. Common Stock | $525.4M | $7.3M | -239.93% | -$0.23 | +1.90% | Buy |
| EOLSEvolus Inc. Common Stock | $517.8M | $297.2M | -17.38% | -$0.80 | -1.01% | Buy |